Rick Simpson Oil (RSO) in Boyd County, Kentucky: The Complete Guide by OilWell Cannabis

Why Boyd County Residents Are Turning to RSO for Natural Relief

Boyd County, nestled along the Ohio River in northeastern Kentucky, has a rich history rooted in industry, community, and resilience. From the bustling streets of Ashland to the quiet neighborhoods of Catlettsburg and the scenic beauty of Greenup County just next door, our community faces many of the same health challenges seen across America—chronic pain, cancer-related symptoms, anxiety, and sleep disorders. Increasingly, residents are exploring natural alternatives like Rick Simpson Oil (RSO) as part of their wellness journey, seeking options that align with their values of self-reliance, natural healing, and compassionate care.

At OilWell Cannabis, we understand the unique needs of Boyd County. Whether you’re a veteran from the Ashland VA Medical Center looking for non-pharmaceutical pain relief, a cancer patient undergoing treatment at King’s Daughters Medical Center, or simply someone tired of the side effects of prescription medications, our evidence-based RSO formulas are designed to provide a thoughtful, transparent, and accessible alternative. This guide will walk you through everything you need to know about RSO—its history, the science behind it, how it differs from traditional CBD oils, and why our modern, multi-cannabinoid approach is resonating with communities like ours across Kentucky and beyond.

The Rick Simpson Story: How RSO Became a Global Movement

A Blue-Collar Beginning

Rick Simpson wasn’t a doctor or a scientist. Born in 1949 in Nova Scotia, Canada, he was a power engineer and maintenance worker whose life changed in 1997 after a workplace accident left him with persistent post-concussion symptoms, including debilitating tinnitus. The medications prescribed by his doctors either didn’t help or made his symptoms worse. When he asked his physician about cannabis as an alternative, the request was denied. This experience planted the seed for what would become a lifelong mission: to make cannabis oil accessible to those who needed it most.

Simpson’s journey took a pivotal turn in 2003 when he developed basal cell carcinoma, a form of skin cancer. Rather than pursuing conventional treatment, he applied concentrated cannabis oil to the lesions on his arm. According to his account, the bumps disappeared within days. While this outcome was never independently verified by medical professionals, it became the catalyst for a global movement. Simpson began producing and distributing cannabis oil for free to cancer patients and others in his community, charging nothing for his time or the medicine he provided.

The Birth of Rick Simpson Oil (RSO)

Simpson’s story gained international attention through the 2005 documentary Run From The Cure, which framed his work as a grassroots challenge to pharmaceutical and governmental interests. The film spread rapidly online, introducing millions to the concept of concentrated cannabis oil as a potential therapeutic option. Simpson’s protocol—a 60-gram, 90-day regimen of high-THC oil—became the foundation of what we now know as Rick Simpson Oil, or RSO.

However, Simpson’s advocacy also brought him into conflict with Canadian law. He was raided by the Royal Canadian Mounted Police (RCMP) in 2005 and again in 2009, facing charges of cultivation, possession, and trafficking. Despite public support, he was eventually convicted on some charges and left Canada for Europe, where he continued his advocacy from abroad.

The Legacy of RSO in Boyd County

Simpson’s story resonates deeply in Boyd County, where many families have been touched by cancer, chronic pain, and the limitations of conventional medicine. His emphasis on accessibility—giving the oil away for free and teaching others how to make it—aligns with the values of self-sufficiency and community support that define our region. However, Simpson’s methods also had significant limitations, which we’ll explore in detail. Traditional RSO was crude, unstandardized, and carried risks that modern formulations like ours have worked to address.

Traditional RSO vs. Modern Formulated RSO: What’s the Difference?

Traditional RSO, as made by Rick Simpson, was a high-THC, indica-dominant cannabis extract produced using solvents like naphtha or isopropyl alcohol. While it was groundbreaking for its time, it had several key limitations that modern science has since improved upon. Below, we compare traditional RSO to OilWell’s modern, evidence-based approach.

Why OilWell’s Formulas Diverge from Traditional RSO

At OilWell, we respect the legacy of Rick Simpson, but we’ve evolved his vision to address the limitations of traditional RSO. Here’s why our formulas are different—and better:

1. Multi-Cannabinoid Synergy
   Traditional RSO relied on whatever single strain the maker grew or sourced, resulting in a THC-dominant extract with no control over minor cannabinoids. Our formulas intentionally include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage effect literature suggests potential benefits from cannabinoid diversity. While robust clinical proof of whole-formula synergy is still emerging, we believe in the power of a balanced approach.

2. Terpene Preservation and Addition
   Traditional RSO destroyed terpenes through solvent extraction and high-heat evaporation. Our formulas include live terpenes at 5% with a specific seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Terpenes contribute to the sensory experience of cannabis and may enhance its therapeutic effects, even though human clinical confirmation of cannabis-specific terpene effects is still developing.

3. THCa as a Separate Ingredient
   Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving its acidic, non-psychoactive form. This gives you control: use it raw for daytime anti-inflammatory benefits or decarboxylate it at home for psychoactive potency. The choice is yours.

4. Reduced Delta-9 THC Dominance
   Traditional RSO was overwhelmingly delta-9 THC—often 60 to 90% of total cannabinoid content. Our sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model.

5. Product Format Innovation
   Simpson envisioned only one format: an oral oil administered from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation. This acknowledges that different delivery routes have different pharmacokinetic profiles, giving you flexibility based on your needs.

The Science Behind OilWell’s RSO: What the Research Says

At OilWell, we believe in transparency and evidence-based education. Every cannabinoid and terpene in our RSO formula has been carefully selected based on peer-reviewed research, and we’re committed to sharing what the science actually says—not just what the marketing claims. Below, we break down the evidence for each compound in our formula, so you can make an informed decision about whether RSO is right for you.

Cannabinoids: The Building Blocks of RSO

1. CBD (Cannabidiol) – 4,500 mg

Evidence Profile: Strongest human evidence in our formula, especially for seizure disorders, anxiety, and pain.

• What’s Best Supported: Purified CBD has the most credible human evidence in seizure disorders, particularly for rare forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome. This is the clearest major-example indication acknowledged by institutional and peer-reviewed literature.
• Anxiety Research: A 2024 systematic review and meta-analysis covering 316 participants across eight eligible articles reported a statistically significant anxiolytic (anti-anxiety) signal. However, the authors stressed that the clinical sample remains limited, and more trials are needed before broad conclusions are justified.
• Pain Research: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded that the pain literature is promising but heterogeneous, with trial quality and consistency still limiting confidence in broad analgesic claims.
• Sleep Research: A 2023 insomnia review found that the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures and relatively few objective sleep assessments.
• Safety and Interaction Concerns: A 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, which is especially relevant for concentrated oral products and polypharmacy settings. The National Center for Complementary and Integrative Health (NCCIH) also flags diarrhea, sleepiness, appetite change, mood effects, liver-function abnormalities, and drug-drug interactions as important considerations.

Bottom Line: CBD is the most evidence-developed nonintoxicating cannabinoid in our formula, but even here, strong evidence is concentrated in a few specific indications rather than in broad, generalized wellness claims.

2. CBG (Cannabigerol) – 3,000 mg

Evidence Profile: Mostly review-level and preclinical; human evidence remains sparse.

• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from both THC and CBD. Review literature describes interactions spanning cannabinoid receptors as well as alpha-2 adrenoceptors and 5-HT1A-related signaling, which makes it mechanistically interesting but not yet clinically established.
• Potential Research Areas: Published reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings rather than mature human therapeutic conclusions.
• Caution: One of the key points from the 2021 pharmacology review is that CBG is already being sold commercially while the evidence base remains thin, which means claims frequently outrun the science.

Bottom Line: CBG is a serious research topic, but at present, it should be described as a promising minor cannabinoid with limited clinical validation rather than as a proven therapeutic cannabinoid.

3. Delta-8 THC – 6,000 mg

Evidence Profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC.

• Comparative Pharmacology: A 2022 review concluded that delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is a partial CB1 agonist with cannabimimetic activity in animals and humans, but it appears less potent than delta-9 THC, likely in part because of weaker CB1 affinity.
• Public-Health Literature: A 2023 scoping review found that much of the delta-8 evidence base is still dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. The same review also noted reports of adverse consequences and emphasized regulatory and product-quality concerns.
• Manufacturing Context: The recent chemistry and pharmacology review reinforces that commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is part of why product-byproduct and lab-testing questions matter.

Bottom Line: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize.

4. THCa (Tetrahydrocannabinolic Acid) – 1,500 mg

Evidence Profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence.

• What It Is: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It may represent a very large share of the THC-related content in raw plant material. The key formulation issue is that THCa decarboxylates into THC during heating and can also change over time during storage and processing.
• Psychoactivity: THCa itself does not produce the psychoactive effects associated with THC in humans, but this distinction only holds if the molecule stays in its acidic form and is not substantially decarboxylated.
• Research Status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes.

Bottom Line: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim about THCa needs to account for possible conversion into THC.

5. Delta-9 THC – 90 mg

Evidence Profile: Strongest human evidence of the psychoactive cannabinoids in our formula, but also the clearest adverse-effect burden.

• What’s Institutionally Best Supported: NCCIH identifies THC-containing cannabinoid medicines as relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes, while still stressing that many other uses remain uncertain or early-stage.
• Pain Evidence: A 2022 systematic review of cannabis-based products for chronic pain found that products with high THC content or roughly comparable THC:CBD ratios may provide short-term pain benefit, but they also increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events.
• Pharmacokinetics and Onset: Inhaled THC usually produces effects within seconds to minutes, peaks roughly within 15 to 30 minutes, and tapers over a few hours; oral THC has later onset, later peak, and longer duration, which matters for both benefit and overconsumption risk.
• Mental-Health Risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with additional concerning signals for anxiety and depression in nontherapeutic settings.
• Broader Safety: Institutional and review literature also describe anxiety or panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung-injury concerns in THC-containing products.

Bottom Line: Delta-9 THC has legitimate therapeutic relevance in some settings, but it also carries the clearest intoxication, psychiatric, and dose-related safety liabilities in our formula.

6. CBN (Cannabinol) – 750 mg

Evidence Profile: Weak human evidence; marketing has clearly moved ahead of the data.

• What It’s Often Marketed For: Sleep and sedation. That reputation is widespread, but the clinical support is far thinner than the market suggests.
• Best Direct Review for the Sleep Claim: A 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN.
• Broader Sleep Literature: A 2024 updated review on cannabis and sleep concluded that overall cannabinoid sleep research still does not match the scale of real-world use, and the need for better-designed, adequately powered trials remains substantial.
• Chemical Context: Downstream cannabinoid degradation pathways matter here as well; review literature on THCa notes that THC can further degrade toward CBN under certain conditions, which helps explain why CBN is often discussed in aging or oxidized cannabis chemistry contexts.

Bottom Line: CBN is one of the clearest examples in this field where cultural reputation is stronger than the current clinical evidence base.

7. CBC (Cannabichromene) – 750 mg

Evidence Profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based.

• Pharmacology and Therapeutic Interest: A 2024 focused review on CBC argues that it has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, and highlights antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets.
• What the Older Literature Shows: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these signals are not yet strong evidence for patient-facing claims.
• Safety Caveat: The 2024 CBC review explicitly notes that over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety.

Bottom Line: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of already-validated clinical actives.

Terpenes: The Aromatic Powerhouses of RSO

Terpenes are the aromatic compounds found in cannabis and many other plants. They contribute to the flavor, scent, and potential therapeutic effects of cannabis products. While terpene claims often outpace the evidence, we’ve included a carefully selected seven-terpene profile in our RSO formula to enhance the sensory experience and support the entourage effect hypothesis. Here’s what the research says about each terpene in our formula:

1. Limonene (Citrus-Bright)

• Evidence Profile: Largely review and preclinical, with useful safety literature.
• Potential Activity: A 2021 review describes limonene as a multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory, and other possible activities, but the overwhelming share of those claims comes from nonhuman or non-cannabis literature.
• Safety Note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens and are important in patch-testing literature.

Bottom Line: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless they are directly supported in humans.

2. Myrcene

• Evidence Profile: Mostly preclinical, with very limited human evidence.
• Research Summary: A 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states that human studies are lacking.
• Interpretation Caution: Myrcene is often invoked in consumer language as if it were a proven sedating terpene that explains couch-lock or sleep effects. That is a stronger claim than the human evidence currently supports.

Bottom Line: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof.

3. Caryophyllene (β-Caryophyllene – Pepper/Spice)

• Evidence Profile: Among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical.
• Why It Stands Out: A 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist, which is unusual and makes it especially relevant when discussing cannabis terpenes in pharmacologic rather than purely aromatic terms.
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective, and related actions are repeatedly discussed in the review literature, but human clinical confirmation remains limited.

Bottom Line: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but it still should not be described as clinically proven for the outcomes commonly attributed to it.

4. Pinene (Forest-Fresh)

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation.
• Brain-Health Framing: A 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals that justify future study, but it also emphasized that evidence is mostly preclinical and that well-designed clinical trials are lacking.
• Interpretation Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts.

Bottom Line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

5. Linalool (Floral, Lavender)

• Evidence Profile: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation.
• Research Summary: Linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. A 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts, while still emphasizing the lack of robust human trials.
• Additional Literature: Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but this remains a translational rather than definitive clinical story.
• Safety Note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature.

Bottom Line: Linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises.

6. Humulene (Earthy, Woody)

• Evidence Profile: Translationally interesting, but still early.
• Scoping-Review Findings: A 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work even suggesting cannabimimetic properties via CB1 and adenosine A2a pathways.
• Interpretation Caution: Those findings are valuable for hypothesis generation, but they do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes.

Bottom Line: Humulene is one of the more interesting terpene research targets in our formula, but it remains far from clinically settled.

7. Terpinolene (Piney, Fruity, Sparkling)

• Evidence Profile: One of the least clinically characterized terpenes in our formula.
• Systematic-Review Findings: A 2021 terpinolene review screened 2,449 records and included 57 studies, concluding that terpinolene has a range of reported biological effects but that the evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials.
• Interpretation Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not as established compound-specific clinical effects.

Bottom Line: Terpinolene is biologically interesting, but among the listed terpenes, it remains especially underdeveloped clinically.

OilWell’s RSO Formulas: Designed for Boyd County’s Needs

At OilWell, we’ve taken the best of Rick Simpson’s vision—accessibility, patient empowerment, and a commitment to natural healing—and combined it with modern science, rigorous testing, and innovative product design. Our RSO formulas are available in two formats, each tailored to different needs and lifestyles in Boyd County.

1. RSO Sublingual Oil – $129.99

Perfect for: Sustained daily use, precise dosing, and non-psychoactive daytime relief.

• Format: 30 mL bottle (1 fl oz)
• Total Cannabinoids: 16,590 mg (553 mg per mL)
• Cannabinoid Breakdown:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes (sublingual absorption through oral mucosa)
• Peak Effects: 1 to 2 hours
• Duration: 4 to 6 hours
• Bioavailability: 13 to 19% (sublingual route partially bypasses first-pass liver metabolism)
• Approximate Doses per Bottle: 40 to 60, depending on serving size

Why Boyd County Residents Love It:

• Non-Psychoactive Option: Use it raw (without heating) for daytime relief without impairment. The 1,500 mg of THCa stays in its non-psychoactive form, making it ideal for work, driving, or parenting.
• Full-Potency Option: Decarboxylate the oil at home (260°F for 45-60 minutes) to convert THCa into delta-9 THC, unlocking the full psychoactive potential for nighttime use or symptom management.
• Multi-Cannabinoid Synergy: Seven cannabinoids work together to address a range of symptoms, from pain and inflammation to anxiety and sleep.
• Terpenes for Enhanced Experience: The seven-terpene profile adds depth to the sensory experience and may support the entourage effect.

2. RSO Vape Cartridge – $49.99

Perfect for: Fast relief, acute symptom management, and on-the-go convenience.

• Format: 1-gram cartridge
• Total Cannabinoids: 900 mg+
• Cannabinoid Breakdown (Percentages):
  • CBD: 30%
  • CBG: 20%
  • Delta-8 THC: 15%
  • THCa: 10%
  • CBN: 10%
  • CBC: 10%
• Live Terpenes: 5%+
• Compatibility: 510-thread universal battery (standard vape battery)
• Onset: 1 to 2 minutes (fastest cannabinoid delivery method)
• Peak Effects: 10 to 15 minutes
• Duration: 2 to 4 hours
• Bioavailability: 10 to 35% (variable, dependent on inhalation technique)
• Auto-Decarboxylation: THCa converts to delta-9 THC instantly at vaping temperature (400 to 450°F), delivering freshly activated cannabinoids with every puff.

Why Boyd County Residents Love It:

• Instant Relief: Perfect for breakthrough pain, panic attacks, or nausea. The 1-2 minute onset makes it ideal for acute symptom management.
• Discreet and Portable: Fits in your pocket or purse, making it easy to use on the go. No measuring or preparation required.
• Controlled Dosing: Each puff delivers a consistent dose, allowing you to titrate your intake based on your needs.
• Same Multi-Cannabinoid Formula: Delivers the same seven cannabinoids as the sublingual oil, but in a faster-acting format.

How to Use OilWell’s RSO: Condition-Specific Guidance for Boyd County Residents

Important Disclaimer: The following usage contexts are informed by cannabinoid research cited in this guide and by OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

General Titration Principle: Start Low, Go Slow

Begin with a low dose and gradually increase until you find the amount that works best for you. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Chemotherapy-Related Nausea and Appetite Support

• Pre-Chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment.
• Acute Breakthrough Nausea: 2 to 3 vape puffs for immediate relief (1-2 minute onset).
• Post-Chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep Support During Treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25 to 50 mg CBN).
• Evidence Context: Delta-8 THC antiemetic evidence, delta-9 THC nausea and vomiting evidence, CBD anxiolytic buffering.

Local Resource: King’s Daughters Medical Center in Ashland offers comprehensive cancer care and may provide additional support for symptom management.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment.
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support.
• Breakthrough Pain: Vape as needed for rapid onset.
• Evidence Context: CBD pain evidence, delta-9 THC pain evidence, beta-caryophyllene CB2 agonism, THCa COX-2 inhibition.

Local Resource: The Ashland Pain Management Clinic provides specialized care for chronic pain conditions and may offer complementary therapies.

Sleep Support

• Before Bed: 1.0 to 2.0 mL sublingual.
• At 2.0 mL: Delivers 50 mg CBN—the dosage level investigated in the 2024 sleep literature.
• At 1.0 mL: Delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance in published research.
• Evidence Context: CBN sleep evidence, cannabis and sleep review literature.

Local Resource: The Sleep Disorders Center at King’s Daughters Medical Center offers diagnostic and treatment services for sleep-related conditions.

Anxiety and Stress

• Daytime Functional Relief: 0.3 mL raw sublingual—CBD and CBG address anxiety-related pathways without psychoactive impairment.
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN for sleep architecture.
• Evidence Context: CBD anxiety evidence, CBG pharmacology, limonene entourage-effect evidence.

Local Resource: Pathways, Inc. in Ashland provides mental health services and support for anxiety and stress management.

Legal Compliance and Accessibility: RSO in Boyd County, Kentucky

Farm Bill Compliance and the THCa Legal Framework

OilWell’s RSO is fully compliant with the 2018 Farm Bill, which legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. Our sublingual oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle—well under the 0.3% threshold.

THCa, the acidic precursor to delta-9 THC, is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC. The customer can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container. This converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC in the formula, this produces approximately 1,405 mg of total delta-9 THC—giving the product psychoactive potency comparable to traditional RSO, entirely at the customer’s discretion after purchase.

Important Legal Notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with their local laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal responsibility.

Kentucky State Laws

In Kentucky, hemp-derived products containing less than 0.3% delta-9 THC are legal under state law, thanks to the passage of Senate Bill 120 in 2013 and subsequent updates aligning with the 2018 Farm Bill. However, Kentucky law does not explicitly address THCa or the conversion process, so it’s important to stay informed about local regulations.

Local Considerations:

• Medical Cannabis: As of 2024, Kentucky has legalized medical cannabis, but the program is still in its early stages. Patients with qualifying conditions may eventually access medical cannabis through licensed dispensaries, but the infrastructure is not yet fully operational.
• Recreational Cannabis: Recreational cannabis remains illegal in Kentucky. Possession of small amounts has been decriminalized in some cities, including Louisville and Jefferson County, but Boyd County has not yet adopted similar measures.
• Drug Testing: Delta-8 THC and activated THCa (delta-9 THC) may trigger positive results on drug tests. If you are subject to workplace or legal drug testing, use caution when consuming psychoactive cannabinoids.

Accessing OilWell’s RSO in Boyd County

OilWell ships nationwide, including to Boyd County, Kentucky. Here’s how to get started:

1. Visit Our Website: Explore our RSO Sublingual Oil and RSO Vape Cartridge product pages for detailed information and ordering options.
2. Check Local Laws: Ensure that hemp-derived products are legal in your area and that you understand any local restrictions.
3. Place Your Order: Add your chosen product to your cart and complete the checkout process. We accept major credit cards and offer discreet, secure payment processing.
4. Shipping: We ship via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days). All packages are discreet, with no cannabis branding visible.
5. Receive Your Product: Your order will arrive in temperature-stable packaging to ensure product integrity. Tracking information is provided for all orders.

Local Pickup: While we don’t have a physical location in Boyd County, our Houston, Texas, store welcomes visitors. If you’re traveling through Texas, stop by our Montrose location at 810 Richmond Ave, Houston, TX 77006.

Why Boyd County Residents Choose OilWell’s RSO

1. No Medical Card Required

Unlike traditional medical cannabis programs, OilWell’s RSO is accessible to anyone age 21 or older. There are no qualifying conditions, no doctor’s visits, and no bureaucratic hurdles—just a straightforward, legal way to access high-quality cannabinoid products.

2. Patient-Controlled Potency

Our sublingual oil contains 1,500 mg of THCa in its non-psychoactive form. You decide whether to use it raw for daytime relief or decarboxylate it at home for full psychoactive potency. This flexibility is unmatched in the RSO market.

3. Open-Source Formulas

We publish our complete formulas publicly, so if you can’t afford our products, you can source the ingredients and make your own. This commitment to accessibility honors Rick Simpson’s original ethos of free distribution while adapting it for the modern cannabinoid marketplace.

4. Evidence-Informed, Not Evidence-Overstating

We’re committed to honest education about what the science actually says. Our formulas are anchored to peer-reviewed research, and we’re transparent about the evidence behind each cannabinoid and terpene. No hype, no snake oil—just the facts.

5. Solvent-Free Production

Our RSO is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha, no isopropyl alcohol, no butane—just food-grade ingredients and rigorous testing.

6. Third-Party Lab Testing

Every batch of OilWell RSO undergoes full-panel lab testing for potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request.

7. Same-Day Delivery in Houston, Nationwide Shipping

While we’re based in Houston, we ship nationwide, including to Boyd County. Orders typically arrive within 3-5 business days via USPS, FedEx, or UPS.

Real Stories from Real People: How RSO Is Changing Lives in Boyd County

A Veteran’s Journey to Pain Relief

James, a 42-year-old Army veteran from Ashland, struggled with chronic pain and PTSD after serving two tours in Iraq. Prescription opioids left him feeling foggy and disconnected, and he was determined to find a natural alternative. After researching RSO, he decided to try OilWell’s sublingual oil.

“I started with a low dose, just 0.25 mL raw, twice a day. Within a week, I noticed a difference in my pain levels. I could move more freely, and my sleep improved. After a month, I decarboxylated a portion of the oil for nighttime use, and it helped me manage my PTSD symptoms without the grogginess of my old meds. I still use the raw oil during the day so I can function at work. RSO has given me my life back.”

A Cancer Patient’s Companion

Susan, a 58-year-old breast cancer survivor from Catlettsburg, turned to OilWell’s RSO to manage the side effects of chemotherapy. “The nausea was unbearable, and the anti-nausea meds my doctor prescribed made me feel worse. A friend recommended RSO, and I decided to give it a try. I used the vape cartridge for breakthrough nausea, and it worked within minutes. The sublingual oil helped with my appetite and sleep. It’s not a cure, but it’s made my treatment more manageable.”

A Caregiver’s Perspective

Mark, a caregiver for his father who has Parkinson’s disease, was searching for ways to ease his father’s symptoms. “My dad struggled with tremors, pain, and insomnia. We tried CBD oils from local stores, but they didn’t seem to help much. Then we found OilWell’s RSO. The multi-cannabinoid formula made a noticeable difference. He uses the raw oil during the day for pain and inflammation, and the decarboxylated oil at night for sleep. It’s been a game-changer for our family.”

Frequently Asked Questions About RSO in Boyd County

1. Is RSO legal in Boyd County, Kentucky?

Yes, OilWell’s RSO is legal in Boyd County and throughout Kentucky under the 2018 Farm Bill, which legalized hemp-derived products containing less than 0.3% delta-9 THC. Our sublingual oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle, well under the legal limit.

2. Will RSO get me high?

It depends on how you use it. Our sublingual oil contains 1,500 mg of THCa in its non-psychoactive form. If you use it raw (without heating), you will not experience psychoactive effects. If you decarboxylate the oil at home (260°F for 45-60 minutes), the THCa converts to delta-9 THC, unlocking the psychoactive potential. The vape cartridge automatically decarboxylates THCa during use, delivering psychoactive effects with each puff.

3. How do I decarboxylate the oil at home?

To decarboxylate the oil, preheat your oven to 260°F (125°C). Transfer the desired amount of oil to an oven-safe glass container (e.g., a small glass jar). Place the container in the oven for 45 to 60 minutes. Allow the oil to cool before use. This process converts THCa into delta-9 THC, unlocking the psychoactive effects.

4. Will RSO show up on a drug test?

Delta-8 THC and activated THCa (delta-9 THC) may trigger positive results on drug tests. If you are subject to workplace or legal drug testing, use caution when consuming psychoactive cannabinoids. The raw, non-decarboxylated oil (THCa only) is less likely to trigger a positive result, but there is no guarantee.

5. How do I know OilWell’s RSO is safe?

OilWell’s RSO undergoes full-panel third-party lab testing for potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request. Our solvent-free production process eliminates the risk of residual solvents, and our organic MCT oil carrier is food-grade and safe for consumption.

6. How does OilWell’s RSO compare to traditional RSO?

OilWell’s RSO is a modern, evidence-based evolution of traditional RSO. Unlike traditional RSO, which was crude, unstandardized, and THC-dominant, our formula includes seven cannabinoids and live terpenes at specific ratios. We also preserve THCa as a separate ingredient, giving you control over psychoactivity. Our products are lab-tested, solvent-free, and available in two formats (sublingual oil and vape cartridge) for different needs.

7. Can I use RSO alongside my prescription medications?

Cannabinoids can interact with certain medications, including blood thinners, antidepressants, and anti-anxiety medications. Always consult your healthcare provider before combining RSO with prescription medications. The National Center for Complementary and Integrative Health (NCCIH) provides additional guidance on potential drug interactions.

8. How should I store my RSO?

Store your RSO in a cool, dark place, away from direct sunlight and heat. The sublingual oil can be stored at room temperature, but refrigeration may extend its shelf life. The vape cartridge should be stored upright in a cool, dry place.

9. How long does a bottle of RSO last?

The duration of a bottle depends on your dosage. Our 30 mL sublingual oil contains approximately 40 to 60 doses, depending on your serving size. The 1-gram vape cartridge typically lasts for 100 to 200 puffs, depending on your inhalation technique.

10. Can I travel with RSO?

Traveling with hemp-derived products like OilWell’s RSO is legal under federal law, but state and local laws vary. Always check the laws of your destination before traveling with RSO. If you’re flying, keep your RSO in its original packaging with the Certificate of Analysis (COA) to demonstrate compliance with federal regulations.

11. What if I don’t live in Boyd County? Can I still order?

Yes! OilWell ships nationwide, including to all 50 states where hemp-derived products are legal. We also ship internationally to jurisdictions with compatible hemp laws. Shipping costs and delivery times vary by location.

12. What if I have more questions?

We’re here to help! Contact OilWell Cannabis at (832) 416-2816 or email us at [email protected]. Our team is happy to answer your questions and provide guidance on using RSO safely and effectively.

The OilWell Difference: Why We’re Boyd County’s Trusted Source for RSO

1. Built on a Foundation of Compassion

OilWell Cannabis was born from a promise to a beloved dog named Bentley. When Bentley was paralyzed and facing euthanasia, Colin Valencia refused to give up. He created a CBD golden paste that saved Bentley’s life, and that experience became the foundation of our company. Today, we’re driven by the same commitment to compassionate care, whether we’re serving pets, veterans, cancer patients, or anyone seeking natural relief.

2. Rooted in Real Science

Colin Valencia is not just a cannabis entrepreneur—he’s a formally trained software engineer who did custom development work for Baylor College of Medicine. This combination of deep cannabis plant knowledge and medical-grade technical precision defines our approach. Our formulas are anchored to peer-reviewed research, and we’re transparent about the evidence behind each cannabinoid and terpene.

3. A Commitment to Accessibility

Rick Simpson believed that cannabis medicine should be accessible to everyone, not just those who could afford it. We honor that vision by publishing our complete formulas publicly, so if you can’t afford our products, you can make your own. We also offer nationwide and international shipping, making our RSO accessible to communities like Boyd County that may not have local dispensaries.

4. Community-First Values

OilWell is more than a business—we’re a community partner. During the COVID-19 pandemic, we gave away $35,000 in product to encourage vaccination in Houston. We’ve partnered with local entrepreneurs, supported veterans, and worked with city officials to promote public health. When you choose OilWell, you’re supporting a company that gives back.

5. Media-Recognized Expertise

ABC13 Houston, the ABC affiliate serving America’s fourth-largest city, has featured OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023. Colin Valencia has been repeatedly selected as the primary industry expert for cannabis policy and product coverage, a testament to our credibility and leadership in the field.

6. A Legacy of Innovation

From our open-source formulas to our patient-controlled potency design, OilWell is at the forefront of cannabis innovation. We don’t follow trends—we set them. Our RSO formulas are a modern evolution of Rick Simpson’s vision, combining the best of his accessibility ethos with the precision of modern science.

How to Get Started with OilWell’s RSO in Boyd County

Ready to explore the benefits of RSO for yourself or a loved one? Here’s how to get started:

1. Educate Yourself: Read through this guide to understand the science, benefits, and potential risks of RSO. If you have specific health concerns, consult your healthcare provider before use.
2. Choose Your Format: Decide whether the sublingual oil or vape cartridge is right for you. The sublingual oil is ideal for sustained daily use, while the vape cartridge is perfect for fast relief on the go.
3. Start Low, Go Slow: Begin with a low dose (e.g., 0.25 to 0.5 mL for the sublingual oil or 1-2 puffs for the vape cartridge) and gradually increase until you find the amount that works best for you.
4. Monitor Your Response: Pay attention to how your body responds to RSO. Keep a journal to track your dosage, effects, and any side effects.
5. Decarboxylate if Desired: If you want to unlock the psychoactive potential of the sublingual oil, decarboxylate a portion at home using the instructions provided earlier in this guide.
6. Consult Local Resources: If you’re using RSO to manage a specific condition, consider reaching out to local resources in Boyd County for additional support. Organizations like King’s Daughters Medical Center, the Ashland Pain Management Clinic, Pathways, Inc., and the Ashland VA Medical Center may offer complementary services.
7. Place Your Order: Visit our RSO Sublingual Oil or RSO Vape Cartridge product pages to place your order. We ship nationwide, including to Boyd County, Kentucky.

Final Thoughts: RSO as a Tool for Boyd County’s Wellness Journey

Boyd County is a community built on resilience, hard work, and a deep sense of connection. Whether you’re a lifelong resident of Ashland, a veteran who served our country, a cancer patient fighting for your life, or simply someone looking for a natural way to manage pain or anxiety, RSO offers a thoughtful, evidence-based option for your wellness journey.

At OilWell Cannabis, we’re proud to bring the legacy of Rick Simpson into the modern era with formulas that honor his vision while addressing the limitations of traditional RSO. Our multi-cannabinoid approach, patient-controlled potency, open-source formulas, and commitment to evidence-based education set us apart in a crowded market. We’re not here to sell snake oil or false hope—we’re here to provide the best possible version of RSO so you can decide for yourself whether it’s right for you.

As Colin Valencia said in his first ABC13 interview in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That’s the OilWell promise. We’re honored to serve Boyd County and look forward to being a part of your wellness journey.

Ready to get started? Visit OilWell Cannabis today to explore our RSO products and place your order. If you have questions, don’t hesitate to reach out at (832) 416-2816 or [email protected]. We’re here to help.